CAPITAL FUND MANAGEMENT S.A.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1323645
PARIS, I0
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$54,894,948
+$54,894,948 QoQ
Shares Held
122,934
Ownership
0.048%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$5,348,420
PutShares
11,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. VRTX ranks #1 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,894,948 | 122,934 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $5,348,420 | 11,500 | Put | Sole | 2024-11-13 | |
| 2024-03-31 | $25,720,155 | 61,530 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $5,643,135 | 13,500 | Put | Sole | 2024-05-15 | |
| 2023-09-30 | $6,085,450 | 17,500 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $14,361,662 | 41,300 | Put | Sole | 2023-11-14 | |
| 2022-12-31 | $4,245,066 | 14,700 | Call | Sole | 2023-02-13 | |
| 2022-09-30 | $6,630,466 | 22,900 | Call | Sole | 2022-11-14 | |
| 2021-03-31 | $3,777,121 | 17,577 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,872,258 | 54,465 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $18,535,725 | 68,116 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,612,563 | 19,333 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,546,675 | 6,500 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $2,784,015 | 11,700 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||